In the ongoing battle of BYOD (bring-your-own-device) vs. provision devices, Zachary Javitt, CEO and co-founder of PillTracker, has firmly come down on one side.
“In terms of helping patients to participate in studies and to help recruit them, I think that a provision device allows you to give a patient a one-stop shop for everything they need in order to run a study in the best way.”
Javitt spoke with Pharma15 Live! at the Disruptive Innovations conference about his company’s provision device, which adheres to blister packs and tracks pill counts and medication adherence in real time.
Do you agree that provision devices are the winner for clinical trials, or is BYOD your method of choice? Let us know!